AU9040591A - Soluble mannose receptor peptides - Google Patents

Soluble mannose receptor peptides

Info

Publication number
AU9040591A
AU9040591A AU90405/91A AU9040591A AU9040591A AU 9040591 A AU9040591 A AU 9040591A AU 90405/91 A AU90405/91 A AU 90405/91A AU 9040591 A AU9040591 A AU 9040591A AU 9040591 A AU9040591 A AU 9040591A
Authority
AU
Australia
Prior art keywords
mannose receptor
receptor peptides
soluble mannose
soluble
peptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU90405/91A
Inventor
Raymond Alan Brian Ezekowitz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Childrens Medical Center Corp
Original Assignee
Childrens Medical Center Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Childrens Medical Center Corp filed Critical Childrens Medical Center Corp
Publication of AU9040591A publication Critical patent/AU9040591A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
AU90405/91A 1990-11-06 1991-11-06 Soluble mannose receptor peptides Abandoned AU9040591A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US609915 1984-05-14
US60991590A 1990-11-06 1990-11-06

Publications (1)

Publication Number Publication Date
AU9040591A true AU9040591A (en) 1992-05-26

Family

ID=24442877

Family Applications (1)

Application Number Title Priority Date Filing Date
AU90405/91A Abandoned AU9040591A (en) 1990-11-06 1991-11-06 Soluble mannose receptor peptides

Country Status (5)

Country Link
EP (1) EP0568539A4 (en)
JP (1) JPH06501620A (en)
AU (1) AU9040591A (en)
CA (1) CA2095729A1 (en)
WO (1) WO1992007579A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997005279A1 (en) 1995-07-27 1997-02-13 Imperial College Of Science, Technology & Medicine Methods of predicting the outcome of infection
EP1008351B1 (en) * 1997-08-21 2006-11-15 Takara Bio Inc. Carcinostatic agents
US7560534B2 (en) 2000-05-08 2009-07-14 Celldex Research Corporation Molecular conjugates comprising human monoclonal antibodies to dendritic cells
IL152652A0 (en) 2000-05-08 2003-06-24 Medarex Inc Human monoclonal antibodies to dendritic cells
EP1594533B1 (en) 2003-01-31 2012-04-11 Celldex Research Corporation Antibody vaccine conjugates and uses therefor
US9259459B2 (en) 2003-01-31 2016-02-16 Celldex Therapeutics Inc. Antibody vaccine conjugates and uses therefor
ES2445755T3 (en) 2007-11-07 2014-03-05 Celldex Therapeutics, Inc. Antibodies that bind human dendritic and epithelial cells 205 (DEC-205)
WO2010060632A1 (en) * 2008-11-27 2010-06-03 Bavarian Nordic A/S Promoters for recombinant viral expression
GB201717977D0 (en) * 2017-10-31 2017-12-13 Univ Court Of The Univ Of Aberdeen Treatment of anaemia
EP4172186A1 (en) 2020-06-30 2023-05-03 Zalvac AB Mannose receptor-derived peptides for neutralizing pore-forming toxins for therapeutic uses

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2868777B2 (en) * 1987-08-20 1999-03-10 チルドレンズ・ホスピタル・コーポレイション Human mannose binding protein
CA1322972C (en) * 1988-03-07 1993-10-12 Pall Corporation Heaterless adsorption system for combined purification and fractionation of air

Also Published As

Publication number Publication date
EP0568539A4 (en) 1994-07-06
JPH06501620A (en) 1994-02-24
EP0568539A1 (en) 1993-11-10
WO1992007579A1 (en) 1992-05-14
CA2095729A1 (en) 1992-05-07

Similar Documents

Publication Publication Date Title
AU639126B2 (en) Oxorapamycin
AU8305491A (en) Novel immunosuppressant peptides
AU8411691A (en) Finger receptor
PL326981A1 (en) Pharmaceutic preparations
AU7203496A (en) Novel peptides
AU8791591A (en) Tnf-muteins
AU4877896A (en) Preparation
AU1892192A (en) High affinity mannose receptor ligands
AU7846991A (en) Aminobenzodiazepines
AU6888794A (en) Shampoo system
PL321686A1 (en) Trensdermal preparation
AU7956191A (en) Transportsystem
AU7804691A (en) N-pyridinesulfonyl-N-pyrimidinyl-or-triazinylureas
AU7358591A (en) Lipopeptide derivatives
AU9040591A (en) Soluble mannose receptor peptides
AU7726391A (en) Slitterscorer
AU6531090A (en) Swagable fitting
AU4554493A (en) Interferon receptor binding peptides
AU7566691A (en) Compostor
AU8740291A (en) 3d-spectacles
AU1314492A (en) Chimaeric polypeptides
AU8219091A (en) Solid preparation
AU7326391A (en) Booth
AU7587991A (en) Electrodermatome
AU8984191A (en) Thiadiazinones